| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/07/1999 | EP0888276A1 Cinnamylidene camphor derivatives and their use as uv-a protecting agents |
| 01/07/1999 | EP0866683A4 Composition and method for treating diseased nails |
| 01/07/1999 | EP0724592B1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors |
| 01/07/1999 | EP0592562B1 Bmp-9 compositions |
| 01/07/1999 | DE19728436A1 Niedrigdosierte 15-Desoxyspergualin-Präparate Low-dose 15-deoxyspergualin preparations |
| 01/07/1999 | CA2295925A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | CA2294232A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 01/07/1999 | CA2241328A1 Use of gamma linolenic acid to prevent oxidative stress |
| 01/06/1999 | CN1204315A New phenylamidine derivatives process for preparing the same and their use as medicaments |
| 01/06/1999 | CN1203810A Ointment for curing red and swollen |
| 01/06/1999 | CN1203807A Medicine for curing recurrent stomatocace and Behcet's syndrome |
| 01/05/1999 | US5856490 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity |
| 01/05/1999 | US5856364 Mixture of pyruvate salt, antioxidant and fatty acid |
| 01/05/1999 | US5856355 Pharmaceutical composition |
| 01/05/1999 | US5855897 Pure cafestol compound |
| 01/05/1999 | US5855891 Ichimeric papillomavirus-like particles |
| 01/05/1999 | CA2044269C Cafeic acid based pharmaceutical and cosmetic depigmenting compositions |
| 01/03/1999 | CA2236462A1 Murc |
| 01/01/1999 | CA2242034A1 Cellulose ester wound dressing |
| 01/01/1999 | CA2236452A1 Gida1 |
| 01/01/1999 | CA2236441A1 Gida2 |
| 01/01/1999 | CA2236435A1 Gida2 |
| 12/30/1998 | WO1998058948A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 12/30/1998 | WO1998058947A1 Dipeptide derivatives as growth hormone secretagogues |
| 12/30/1998 | WO1998058926A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
| 12/30/1998 | WO1998058922A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 12/30/1998 | WO1998058919A1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 12/30/1998 | WO1998058671A1 Topical treatment of psoriasis using neutralizing antibodies to il-8 |
| 12/30/1998 | WO1998044895A3 Cosmetic and dermatological agent with a hard-magnetic particle base |
| 12/30/1998 | WO1998040404A3 Secreted proteins and polynucleotides encoding them |
| 12/30/1998 | EP0887416A2 Human AFC1 |
| 12/30/1998 | EP0887415A2 Human RCE1 |
| 12/30/1998 | EP0887406A2 A member of the FRZB family, franzzled |
| 12/30/1998 | EP0887072A1 Use of sulfites and meta bisulfites, for the manufacturing of cosmetic or pharmaceutical compositions, principally for dermatologig, having an inhibitory effect on melanogenesis or skin whitening |
| 12/30/1998 | EP0886517A1 Method for reducing skin oils and grease |
| 12/30/1998 | EP0886515A1 Use of n-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss |
| 12/30/1998 | EP0801570A4 Formulations and methods for reducing skin irritation |
| 12/30/1998 | CN1203590A Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 12/30/1998 | CN1203529A 'Gamma'-RAR antagonist ligand or 'alpha'-RAR agonist ligand as apoptosis inhibitor |
| 12/30/1998 | CN1203528A Use of gamma-RAR-specific agonist ligand to increase apoptosis rate |
| 12/30/1998 | CN1203105A Process for preparing medicine for curing intractable psoriasis |
| 12/30/1998 | CN1203075A Skin nutritious agent |
| 12/30/1998 | CN1203074A External-use ointment for face and its preparing process |
| 12/30/1998 | CN1041417C Sulfur-containing heterocyclic compounds, use and drug containing same |
| 12/30/1998 | CA2294601A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 12/29/1998 | US5854229 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 12/29/1998 | US5854220 Glial mitogenic factors, their preparation and use |
| 12/29/1998 | US5853742 Cosmetic compositions containing lactate dehydrogenase inhibitors |
| 12/29/1998 | US5853732 Pharmaceutical compositions containing kukui nut oil |
| 12/29/1998 | US5853705 Anti-aging cosmetic composition |
| 12/29/1998 | CA2129554C Recombinant antibodies specific for tnf-.alpha. |
| 12/29/1998 | CA2002859C Method of treating epithelial disorders |
| 12/29/1998 | CA1340295C Human somatomedin carrier protein subunits and process for procucing them |
| 12/24/1998 | DE19722846A1 Leukotrien-B¶4¶-Derivate, insbesondere 7-Methylcyclohexyl-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular 7-methylcyclohexyl-LTB¶4¶ antagonists |
| 12/24/1998 | CA2234418A1 Human afc1 |
| 12/24/1998 | CA2234402A1 Human rce1 |
| 12/23/1998 | WO1998057976A1 Secreted proteins and polynucleotides encoding them |
| 12/23/1998 | WO1998057966A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 12/23/1998 | WO1998057936A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 12/23/1998 | EP0885308A1 Compositions and methods of making embryonic stem cells |
| 12/23/1998 | EP0885299A1 Wsx receptor and ligands |
| 12/23/1998 | EP0885227A1 PYRIMIDO 5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION |
| 12/23/1998 | EP0885226A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production |
| 12/23/1998 | EP0885204A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 12/23/1998 | EP0885060A1 Solid and semi-solid hydrocarbon gels and uses thereof |
| 12/23/1998 | EP0885013A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
| 12/23/1998 | EP0884997A1 Compositions containing an antifungal and a sulfur compound |
| 12/23/1998 | EP0884950A1 A method of killing or inhibiting microbial cells |
| 12/23/1998 | EP0610368B1 Treatment of acne or of pseudofolliculitis barbae |
| 12/23/1998 | CN1202904A Cyclopeptolides |
| 12/23/1998 | CN1202893A Novel isoxazoline and isoxazole fibrinogen deceptor antagonists |
| 12/23/1998 | CN1202822A Use of a THF alpha antagonist for treating neurogenic skin redness |
| 12/23/1998 | CN1202365A Chunyu medical ointment for burn and scald |
| 12/23/1998 | CN1202359A Medicine for preventing sexual disease |
| 12/23/1998 | CN1041311C Method for preparing benzopyran and related LTB4 antagonists |
| 12/23/1998 | CA2294569A1 Secreted proteins and polynucleotides encoding them |
| 12/23/1998 | CA2294137A1 Novel aryloxy substituted pyrimidine imidazole compounds |
| 12/23/1998 | CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors |
| 12/22/1998 | US5852060 Antipsoriatic compositions, method of making, and method of using |
| 12/22/1998 | US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 12/22/1998 | US5852024 Treatment and prevention of adhesions |
| 12/22/1998 | US5852002 Treatment of conditions and disease |
| 12/22/1998 | US5851999 FLK-1 is a receptor for vascular endothelial growth factor |
| 12/22/1998 | US5851990 bFGF mutein and its production |
| 12/22/1998 | US5851978 Soap composition |
| 12/22/1998 | US5851540 Composition, barrier film, and method for preventing contact dermatitis |
| 12/22/1998 | US5851538 Retinoid formulations in porous microspheres for reduced irritation and enhanced stability |
| 12/22/1998 | US5851522 Enhancing keratinocyte migration |
| 12/17/1998 | WO1998056909A2 Secreted proteins and polynucleotides encoding them |
| 12/17/1998 | WO1998056818A1 Human l105 proteins and polynucleotides encoding same |
| 12/17/1998 | WO1998056783A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 12/17/1998 | WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds |
| 12/17/1998 | WO1998056375A1 Tazarotene and uvb phototherapy treatment for psoriasis |
| 12/17/1998 | WO1998056373A1 Isoflavonoids for treatment and prevention of aging skin and wrinkles |
| 12/17/1998 | WO1998056371A1 Use of cis-6-hexadecenoic acid for treating psoriasis, allergies, auto-immune disorders and dry, sensitive skin |
| 12/17/1998 | WO1998042708A3 Pharmaceutically active tricyclic amines |
| 12/17/1998 | WO1998039034A3 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions |
| 12/17/1998 | DE19724622A1 Verwendung von cis-6-Hexadecensäure zur Behandlung von Psoriasis, Allergien und Autoimmunerkrankungen Using cis-6-hexadecenoic acid for the treatment of psoriasis, allergies and autoimmune diseases |
| 12/17/1998 | CA2295982A1 Human l105 proteins and polynucleotides encoding same |
| 12/17/1998 | CA2294062A1 Isoflavonoids for treatment and prevention of aging skin and wrinkles |